Could a common diabetes drug ease stomach troubles in rare MODY?
NCT ID NCT07029009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests liraglutide, a drug used for type 2 diabetes, in 50 adults with MODY, a rare genetic form of diabetes. The goal is to see if it improves blood sugar control and reduces stomach issues like nausea. Researchers will also study participants' cells to understand why the drug might help.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURITY-ONSET DIABETES OF THE YOUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive genetic diabetes hunt launches in china
- Scientists turn skin and blood into insulin factories to fight diabetes
- New online groups aim to ease the loneliness of type 1 diabetes
- App-Based videos aim to boost birth weights in diabetic pregnancies
- New study tests best way to manage rare diabetes in pregnancy